Shareholdings
| Concept |
As at 2024-07-31 |
2023-08-01 to 2024-07-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues |
4
xbrli:pure
|
— |
| Carrying amount |
559,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
1
xbrli:pure
|
| Total acquisition cost for increased shares | — |
99,000,000
JPY
|
| Reason for increase in number of shares | — |
株式会社バッカス・バイオイノベーションは、微生物を遺伝子改変したプラットフォームを作成し、様々な分野で微生物を使った素材を製造する技術を有しております。同社は、当社の「バイオものづくり革命推進事業」においても、重要な委託先であることを踏まえ、株式を保有しております。
|
| Shares other than those not listed | ||
| Number of issues |
4
xbrli:pure
|
— |
| Carrying amount |
1,737,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
xbrli:pure
|
| Total acquisition cost for increased shares | — |
JPY
|
| Reason for increase in number of shares | — |
|